The following information is based on an Exchange Notice from OMX Nordic Exchange Copenhagen published 23 November, 2007 and may be subject to change. Novo Nordisk A/S (Novo) will carry out a share split whereby every share will be replaced by two new shares (2:1). OMX Derivatives Markets will carry out a re-calculation of options and futures in Novo.
Attachments
